SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cavalry who wrote (451)10/8/1998 2:48:00 AM
From: Cavalry  Read Replies (1) of 857
 
this is the part of latest release that spells doom for heb shorts

various patients, who have participated in its long-term treatment evaluation programs of Ampligen(R) for chronic fatigue syndrome (CFS), will present detailed first-hand accounts at the upcoming American Association for Chronic Fatigue Syndrome Research Conference in Boston, Massachusetts. The patient groups will speak at approximately 6 PM on Saturday, October 10, 1998, and Monday, October 12, 1998, at approximately 8 AM

NOTHING MORE CONVINCING THAN FIRST HAND TESTIMONIALS

cav
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News